Literature DB >> 15828826

Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.

Kennerly S Patrick1, Robin L Williard, Adam L VanWert, Justin J Dowd, John E Oatis, Lawrence D Middaugh.   

Abstract

Ethanol elevates methylphenidate (1) plasma concentrations and yields the metabolite ethylphenidate (2). The therapeutic implications are under investigation. The IC(50) for dopamine reuptake inhibition by (+)-2 was 27 nM compared to 367 nM for cocaine and 1730 nM for (-)-2. Binding selectivity for dopamine versus norepinephrine transporters was greater for (+)-2 than for cocaine. Intraperitoneal (+)-2 was approximately half as active as (+)-1 in stimulating mouse motor activity at 5 mg/kg, but (+)-2 was as active as (+)-1 at 10 mg/kg.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15828826     DOI: 10.1021/jm0490989

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

Review 1.  Metabolomics of Methylphenidate and Ethylphenidate: Implications in Pharmacological and Toxicological Effects.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

Review 2.  Evolution of stimulants to treat ADHD: transdermal methylphenidate.

Authors:  Kennerly S Patrick; Arthur B Straughn; Jeb S Perkins; Mario A González
Journal:  Hum Psychopharmacol       Date:  2009-01       Impact factor: 1.672

3.  Identification of alcohol-dependent clopidogrel metabolites using conventional liquid chromatography/triple quadrupole mass spectrometry.

Authors:  Zhe-Yi Hu; S Casey Laizure; Vanessa L Herring; Robert B Parker
Journal:  Rapid Commun Mass Spectrom       Date:  2014-06-15       Impact factor: 2.419

4.  Oral and transdermal DL-methylphenidate-ethanol interactions in C57BL/6J mice: potentiation of locomotor activity with oral delivery.

Authors:  Guinevere H Bell; William C Griffin; Kennerly S Patrick
Journal:  Pharmacol Biochem Behav       Date:  2011-09-08       Impact factor: 3.533

5.  Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics.

Authors:  K S Patrick; A B Straughn; R R Minhinnett; S D Yeatts; A E Herrin; C L DeVane; R Malcolm; G C Janis; J S Markowitz
Journal:  Clin Pharmacol Ther       Date:  2007-03       Impact factor: 6.875

Review 6.  Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance.

Authors:  James H Ho; George P Bailey; John R H Archer; Paul I Dargan; David M Wood
Journal:  Eur J Clin Pharmacol       Date:  2015-07-22       Impact factor: 2.953

7.  Enantiospecific gas chromatographic-mass spectrometric analysis of urinary methylphenidate: implications for phenotyping.

Authors:  Natalie L LeVasseur; Hao-Jie Zhu; John S Markowitz; C Lindsay DeVane; Kennerly S Patrick
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-12-04       Impact factor: 3.205

8.  Differential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humans.

Authors:  Kennerly S Patrick; Arthur B Straughn; Owen T Reeves; Hilary Bernstein; Guinevere H Bell; Erica R Anderson; Robert J Malcolm
Journal:  Drug Metab Dispos       Date:  2012-10-25       Impact factor: 3.922

Review 9.  Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.

Authors:  Kennerly S Patrick; Timothy R Corbin; Cristina E Murphy
Journal:  J Pharm Sci       Date:  2014-10-09       Impact factor: 3.534

10.  Interactive effects of methylphenidate and alcohol on discrimination, conditioned place preference and motor coordination in C57BL/6J mice.

Authors:  William C Griffin; Robin W McGovern; Guinevere H Bell; Patrick K Randall; Lawrence D Middaugh; Kennerly S Patrick
Journal:  Psychopharmacology (Berl)       Date:  2012-09-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.